Immunovant | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 15 16:21 ET
Immunovant | 8-K: Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
Feb 12 07:09 ET
Immunovant | 8-K: Current report
Jan 9 00:00 ET
Immunovant | 8-K: Current report
Dec 20, 2023 16:37 ET
Immunovant | 8-K: Current report
Nov 28, 2023 07:43 ET
Immunovant | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Nov 9, 2023 08:49 ET
Immunovant | 8-K: Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended September 30, 2023
Nov 9, 2023 07:06 ET
Immunovant | 8-K: Current report
Sep 28, 2023 17:23 ET
Immunovant | 8-K: Current report
Sep 26, 2023 07:45 ET
Immunovant | 8-K: Current report
Aug 23, 2023 16:48 ET
Immunovant | 8-K: Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023
Aug 10, 2023 07:10 ET
Immunovant | DEFA14A: Others
Jun 26, 2023 07:35 ET
Immunovant | DEF 14A: Definitive information statements
Jun 26, 2023 07:26 ET
Immunovant | 8-K: Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023
May 22, 2023 07:03 ET
Immunovant | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 5, 2023 16:01 ET
Immunovant | 8-K: Current report
Mar 27, 2023 07:07 ET
Immunovant | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 3, 2023 08:21 ET
Immunovant | 8-K: Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended December 31, 2022
Feb 3, 2023 07:05 ET
Immunovant | 8-K: Current report
Jan 9, 2023 08:38 ET
Immunovant | 8-K: Current report
Dec 8, 2022 07:06 ET
No Data
No Data